(1 July 2005–31 October 2006 and 1 July 2012–31 October 2013) in the ED of Asahikawa Red Cross Hospital.ResultsThe number of DMISH cases (48 during 2005–2006, and 47 during 2012–2013) and their proportions of all emergency visits (0.77 % during 2005–2006, and 0.79 % ...
(PAS) and Jones’ silver stain to evaluate glomerular basement membranes. Scarring was assessed using Masson trichrome stain. Majority of cases were also stained with congo red stain to exclude amyloidosis. All compartments of the kidney were ...
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.PubMedGoogle ScholarCrossref 41. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The...
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-8539742976Google ScholarCrossref 32. Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR...
Diabetes management was also part of the overall treatment plan for this patient. Case report 2 (Dr. Wahdan) A 41-year-old man was seen in the emergency room for severe pain, oedema and redness of his left lower limb. The patient experienced severe pain in his ...
Therefore, it is important to clarify the types and functions of immune cells involved in DR for the treatment of DR. In this study, we used the ImmuCellAI and xCell platforms to analyse immune cell infiltration in DR and demonstrated that macrophages were present and statistically significant ...
Diabetic ketoacidosis (DKA) is a life-threatening hyperglycemia emergency in diabetes. Although DKA is predominantly associated with type I diabetes, it manifests in type 2 diabetes (T2D) patients [2] at a low rate. With the population of T2D patients increasing, the absolute number of patients...
corticosteroids in patients with COPD are not associated with an increased risk of new onset DM, hyperglycemia or a significant change in HbA1clevels [172,173]. On the other hand, metformin treatment over a2–year follow-up period in patients with coexisting DM and COPD reduced emergency room ...
Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA. 2014;311(22):2288-2296. doi:10.1001/jama.2014.4312PubMedGoogle ScholarCrossref 57. Hernán MA, Robins JM. Using big data to ...
doi:10.1097/IAE.0000000000002004 PubMedGoogle ScholarCrossref 13. Korobelnik J-F, Kleijnen J, Lang SH, et al. Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME). BMC Ophthalmol. 2015;15:52. doi...